No abstract available
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers / metabolism
-
Delivery of Health Care / economics
-
Delivery of Health Care / methods*
-
Drug Repositioning
-
Female
-
Genital Neoplasms, Female / economics
-
Genital Neoplasms, Female / metabolism
-
Genital Neoplasms, Female / therapy*
-
Health Care Reform / economics
-
Humans
-
Palliative Care / methods
-
Poly(ADP-ribose) Polymerase Inhibitors*
-
Quality of Life
-
Reimbursement Mechanisms
-
Survivors
-
Vulnerable Populations
Substances
-
Angiogenesis Inhibitors
-
Biomarkers
-
Poly(ADP-ribose) Polymerase Inhibitors